Purpose: The authors describe a new generation of porous orbital implant ma
de of aluminum oxide (Al2O3) and compare it with the hydroxyapatite orbital
implants (Bio-Eye and FCI hydroxyapatite).
Methods: The authors examined the new implant macroscopically, with chemica
l analysis and microscopically with scanning electron microscopy. Animal im
plantation studies were performed using six adult male New Zealand albino r
abbits. Implant vascularization was evaluated by means of magnetic resonanc
e imaging and histopathologic sectioning.
Results: The Bioceramic orbital implant was found to have very uniform pore
structure with an average pore size of 500 mu m. The implant was 99.9% alu
minum oxide on x-ray diffraction. Magnetic resonance imaging in vivo vascul
arization studies demonstrated enhancement of the implant to its center by
4 weeks after implantation in the rabbit. Histopathologically, fibrovascula
rization occurred uniformly throughout the implant and was noted by 4 weeks
.
Conclusions: The Bioceramic orbital implant represents a new porous orbital
implant that has a very regular and extensive interconnected pore system,
is as biocompatible as hydroxyaparite, is easy to manufacture, structurally
strong, and free of contaminants. It is manufactured with no disruption to
marine life ecosystems as may occur in the harvesting of coral for other o
rbital implants. It is less expensive than currently available hydroxyapati
te implants and was approved by the U.S. Food and Drug Administration in Ap
ril 2000.